Cargando…

Allogeneic HSCT in Adolescents and Young Adults With Primary Immunodeficiencies

Significant advances in hematopoietic transplantation over the past 20 years, have facilitated the safe transplantation of older adults with higher co-morbidities. In pediatric practice these advances have simultaneously improved outcomes for sicker children with complex, rare diseases including the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Emma C., Albert, Michael H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821713/ https://www.ncbi.nlm.nih.gov/pubmed/31709207 http://dx.doi.org/10.3389/fped.2019.00437

Ejemplares similares

Risk and promise: an 11-year, single-center retrospective study of severe acute GVHD in pediatric patients undergoing allogeneic HSCT for nonmalignant diseases
por: Zaidman, Irina, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplantation for Primary Immunodeficiencies
por: Gennery, Andrew R., et al.
Publicado: (2019)

Prevention and management of human cytomegalovirus in pediatric HSCT recipients: A review
por: Hiskey, Lisa, et al.
Publicado: (2022)

A Guidance for Concomitant Drug Reconciliation Prior to Allogeneic Hematopoietic Cell Transplantation in Children and Young Adults
por: Apsel Winger, Beth, et al.
Publicado: (2021)

Case Report: Zellweger Syndrome and Humoral Immunodeficiency: The Relevance of Newborn Screening for Primary Immunodeficiency
por: Fazi, C., et al.
Publicado: (2022)

Transition for Adolescents and Young Adults With Asthma
por: Withers, Adelaide LIndsay, et al.
Publicado: (2019)

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome
por: Greco, Raffaella, et al.
Publicado: (2021)

Allogeneic HSCT for Symptomatic Female X-linked Chronic Granulomatous Disease Carriers
por: Tsilifis, Christo, et al.
Publicado: (2023)

SARS-CoV-2 Infection and Active, Multiorgan, Severe cGVHD After HSCT for Adolescent ALL: More Luck Than Understanding? A Case Report
por: Zubarovskaya, Natalia, et al.
Publicado: (2022)

Hospital survival following pediatric HSCT: changes in complications, ICU therapies and outcomes over 10 years
por: Olson, Taylor L., et al.
Publicado: (2023)

Pulmonary Manifestations of Primary Immunodeficiency Disorders in Children
por: Jesenak, Milos, et al.
Publicado: (2014)

Bispecific Antibodies and Other Non-CAR Targeted Therapies and HSCT: Decreased Toxicity for Better Transplant Outcome in Paediatric ALL?
por: Kállay, Krisztián Miklós, et al.
Publicado: (2022)

Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood
por: Day, James W., et al.
Publicado: (2022)

What Is the Role of HSCT in Philadelphia-Chromosome–Positive and Philadelphia-Chromosome–Like ALL in the Tyrosine Kinase Inhibitor Era?
por: Vettenranta, Kim, et al.
Publicado: (2022)

Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations
por: He, Si-jia, et al.
Publicado: (2023)

Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity
por: Nicholson, Bethany, et al.
Publicado: (2022)

Conditioning Perspectives for Primary Immunodeficiency Stem Cell Transplants
por: Shaw, Peter, et al.
Publicado: (2019)

Primary Immunodeficiencies and Oncological Risk: The Experience of the Children's Hospital of Brescia
por: Maffeis, Marianna, et al.
Publicado: (2019)

Sertraline Pharmacokinetics in HIV-Infected and Uninfected Children, Adolescents, and Young Adults
por: Hanan, Nathan John, et al.
Publicado: (2019)

Model of Care for Adolescents and Young Adults with Cancer: The Youth Project in Milan
por: Magni, Chiara, et al.
Publicado: (2016)

Multiple breath washout and oscillometry after allogenic HSCT: a scoping review
por: Sonneveld, Nicole, et al.
Publicado: (2023)

Late Endocrine Effects After HSCT in Children With Nonmalignant Diseases; A Single Center Cohort Analysis
por: de Kloet, Liselotte C, et al.
Publicado: (2021)

Photon or Proton Therapy for Adolescent and Young Adult Tumors Focused on Long-Term Survivors
por: Mizumoto, Masashi, et al.
Publicado: (2021)

Predictors of Memory Deficits in Adolescents and Young Adults with Congenital Heart Disease Compared to Healthy Controls
por: Pike, Nancy A., et al.
Publicado: (2016)

Higher hydroxyurea adherence among young adults with sickle cell disease compared to children and adolescents
por: Reddy, Paavani S., et al.
Publicado: (2022)

Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives
por: Castagnoli, Riccardo, et al.
Publicado: (2019)

Greatly reduced risk of EBV reactivation in rituximab-experienced recipients of alemtuzumab-conditioned allogeneic HSCT
por: Burns, D M, et al.
Publicado: (2016)

Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study
por: Crowder, Sylvia L., et al.
Publicado: (2022)

Haematopoietic Stem Cell Transplantation in Adolescents and Young Adults With Acute Lymphoblastic Leukaemia: Special Considerations and Challenges
por: Calvo, Charlotte, et al.
Publicado: (2022)

Editorial: Advances in the care of the pediatric pulmonary hypertension patient: from the neonate to the adolescent-young adult patient
por: Avitabile, Catherine M., et al.
Publicado: (2023)

Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study
por: Achini-Gutzwiller, Federica R., et al.
Publicado: (2023)

Evans Syndrome in Childhood: Long Term Follow-Up and the Evolution in Primary Immunodeficiency or Rheumatological Disease
por: Rivalta, Beatrice, et al.
Publicado: (2019)

Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency
por: Gennery, Andrew R., et al.
Publicado: (2019)

Locoregional Control and Survival in Children, Adolescents, and Young Adults With Localized Head and Neck Alveolar Rhabdomyosarcoma—The French Experience
por: Machavoine, Roxane, et al.
Publicado: (2022)

A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain
por: Zhang, Shannon, et al.
Publicado: (2019)

Clinical significance of T cell receptor excision circle (TREC) quantitation after allogenic HSCT
por: Mikhael, Neveen Lewis, et al.
Publicado: (2019)

A horse or a zebra? Unusual manifestations of common cutaneous infections in primary immunodeficiency pediatric patients
por: Ollech, Ayelet, et al.
Publicado: (2023)

Long-term follow-up in common variable immunodeficiency: the pediatric-onset and adult-onset landscape
por: Carrabba, Maria, et al.
Publicado: (2023)

The economic burden of NIPC and BOS following allogeneic HSCT in patients with commercial insurance in the United States
por: Sacks, Naomi C., et al.
Publicado: (2022)

Prevalence, risk factors, and vaccine effectiveness of COVID-19 infection in thai children, adolescents, and young adults in the omicron era
por: Chaiyakulsil, Chanapai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_99fibgalefnb83k75l9aalvitt